These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 33368325

  • 1. Breast cancer patient-derived scaffolds as a tool to monitor chemotherapy responses in human tumor microenvironments.
    Leiva MC, Garre E, Gustafsson A, Svanström A, Bogestål Y, Håkansson J, Ståhlberg A, Landberg G.
    J Cell Physiol; 2021 Jun; 236(6):4709-4724. PubMed ID: 33368325
    [Abstract] [Full Text] [Related]

  • 2. Patient-derived scaffolds representing breast cancer microenvironments influence chemotherapy responses in adapted cancer cells consistent with clinical features.
    Leiva MC, Gustafsson A, Garre E, Ståhlberg A, Kovács A, Helou K, Landberg G.
    J Transl Med; 2023 Dec 20; 21(1):924. PubMed ID: 38124067
    [Abstract] [Full Text] [Related]

  • 3. Optimized alginate-based 3D printed scaffolds as a model of patient derived breast cancer microenvironments in drug discovery.
    Svanström A, Rosendahl J, Salerno S, Leiva MC, Gregersson P, Berglin M, Bogestål Y, Lausmaa J, Oko A, Chinga-Carrasco G, Petronis S, Standoft S, Ståhlberg A, Håkansson J, Landberg G.
    Biomed Mater; 2021 Jun 25; 16(4):. PubMed ID: 34030145
    [Abstract] [Full Text] [Related]

  • 4. Patient-derived scaffolds influence secretion profiles in cancer cells mirroring clinical features and breast cancer subtypes.
    Persson E, Gregersson P, Gustafsson A, Fitzpatrick P, Rhost S, Ståhlberg A, Landberg G.
    Cell Commun Signal; 2021 Jun 05; 19(1):66. PubMed ID: 34090457
    [Abstract] [Full Text] [Related]

  • 5. Induction of CXCR2 ligands, stem cell-like phenotype, and metastasis in chemotherapy-resistant breast cancer cells.
    Sharma B, Varney ML, Saxena S, Wu L, Singh RK.
    Cancer Lett; 2016 Mar 28; 372(2):192-200. PubMed ID: 26797460
    [Abstract] [Full Text] [Related]

  • 6. Three-dimensional tissue culture model of human breast cancer for the evaluation of multidrug resistance.
    Ding Y, Liu W, Yu W, Lu S, Liu M, Kaplan DL, Wang X.
    J Tissue Eng Regen Med; 2018 Sep 28; 12(9):1959-1971. PubMed ID: 30055109
    [Abstract] [Full Text] [Related]

  • 7. Breast Cancer Spheroids Reveal a Differential Cancer Stem Cell Response to Chemotherapeutic Treatment.
    Reynolds DS, Tevis KM, Blessing WA, Colson YL, Zaman MH, Grinstaff MW.
    Sci Rep; 2017 Sep 04; 7(1):10382. PubMed ID: 28871147
    [Abstract] [Full Text] [Related]

  • 8. Enrichment of breast cancer stem-like cells by growth on electrospun polycaprolactone-chitosan nanofiber scaffolds.
    Sims-Mourtada J, Niamat RA, Samuel S, Eskridge C, Kmiec EB.
    Int J Nanomedicine; 2014 Sep 04; 9():995-1003. PubMed ID: 24570583
    [Abstract] [Full Text] [Related]

  • 9. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.
    Pledgie-Tracy A, Billam M, Hacker A, Sobolewski MD, Woster PM, Zhang Z, Casero RA, Davidson NE.
    Cancer Chemother Pharmacol; 2010 May 04; 65(6):1067-81. PubMed ID: 19727732
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Chemotherapy-Induced Extracellular Vesicle miRNAs Promote Breast Cancer Stemness by Targeting ONECUT2.
    Shen M, Dong C, Ruan X, Yan W, Cao M, Pizzo D, Wu X, Yang L, Liu L, Ren X, Wang SE.
    Cancer Res; 2019 Jul 15; 79(14):3608-3621. PubMed ID: 31118200
    [Abstract] [Full Text] [Related]

  • 14. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy.
    Fillmore CM, Kuperwasser C.
    Breast Cancer Res; 2008 Jul 15; 10(2):R25. PubMed ID: 18366788
    [Abstract] [Full Text] [Related]

  • 15. Association of ABCB1, β tubulin I, and III with multidrug resistance of MCF7/DOC subline from breast cancer cell line MCF7.
    Li W, Zhai B, Zhi H, Li Y, Jia L, Ding C, Zhang B, You W.
    Tumour Biol; 2014 Sep 15; 35(9):8883-91. PubMed ID: 24894670
    [Abstract] [Full Text] [Related]

  • 16. PRMT5 determines the sensitivity to chemotherapeutics by governing stemness in breast cancer.
    Wang Z, Kong J, Wu Y, Zhang J, Wang T, Li N, Fan J, Wang H, Zhang J, Ling R.
    Breast Cancer Res Treat; 2018 Apr 15; 168(2):531-542. PubMed ID: 29185119
    [Abstract] [Full Text] [Related]

  • 17. Chemoresistance of Lung and Breast Cancer Cells Growing Under Prolonged Periods of Serum Starvation.
    Yakisich JS, Venkatadri R, Azad N, Iyer AKV.
    J Cell Physiol; 2017 Aug 15; 232(8):2033-2043. PubMed ID: 27504932
    [Abstract] [Full Text] [Related]

  • 18. Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells.
    Hu K, Law JH, Fotovati A, Dunn SE.
    Breast Cancer Res; 2012 Feb 06; 14(1):R22. PubMed ID: 22309939
    [Abstract] [Full Text] [Related]

  • 19. Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer.
    Watanabe T, Oba T, Tanimoto K, Shibata T, Kamijo S, Ito KI.
    PLoS One; 2021 Feb 06; 16(6):e0252822. PubMed ID: 34101751
    [Abstract] [Full Text] [Related]

  • 20. A study with cancer stem cells and three-dimensional tumoroids: investigation of the combined effects of 5-fluorouracil and doxorubicin in breast cancer.
    Erden Tayhan S.
    Med Oncol; 2024 Jun 23; 41(7):185. PubMed ID: 38910198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.